Pharma CEOs defended their high prescription drug costs, stating that the curren...
Nippon will pay $10m upfront and up to $275m in milestone-based payments for the...
Philips' has recalled a number of high profile medical devices in recent years, ...
Novo Nordisk’s plans to buy Catalent has raised objections related to the risk o...
The survey by CRO Worldwide Clinical Trials shows that pharma and biotechs favou...
Janssen has filed a Type II extension of indication application with the EMA see...
The FDA estimates that taking menthol cigarettes off the market would save up to...
A neurologist explains why knowing about CTE doesn’t keep Americans from watchin...
Private equity investment in health care ramped up in three sectors: cardiology,...
It’s not uncommon for scientists to disagree over authorship. But it’s highly un...
Rep. Cathy McMorris Rodgers, who leads the House Energy & Commerce Committee, an...
Senate Democrats wants Medicare to take more aggressive action to prevent health...
This week on "The Readout LOUD": Has AI really solved biology? What can machines...
In a jam-packed hearing room, Sen. Bernie Sanders pressed CEOs with familiar que...
Companies have been pushing high-dose versions of naloxone to reverse overdose, ...
.@adamfeuerstein previews the expected readout from Gritstone Bio’s neoantigen c...
